Mid-Year Report

DAVIDSON & COMPANY for HEALTH FREEDOM FOUNDATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007

LobbyistCovered position, as disclosed
JAMES H DAVIDSON N/A
ANITA ESTELL N/A
TEDDY EYNON N/A
MARTIN FROST N/A
ELIZABETH POWELL N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 468 (110th), H.R. 380 (110th), S. 484 (110th), S. 251 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.